Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
COVID-19 therapies and their impact on QT interval prolongation: A multicentre retrospective study on 196 patients.
Bianco M, Biolè CA, Campagnuolo S, Pietrangiolillo F, Spirito A, Galluzzo A, Nuñez-Gil I, Destefanis P, Luciano A, Carvalho P, Varalda GP, Previti A, Gravellone M, Travieso Gonzalez A, Ugo F, Pivano G, Rametta F, Perboni A, Pozzi R, Montagna L, Cerrato E. Bianco M, et al. Among authors: gravellone m. Int J Cardiol Heart Vasc. 2020 Oct;30:100637. doi: 10.1016/j.ijcha.2020.100637. Epub 2020 Sep 11. Int J Cardiol Heart Vasc. 2020. PMID: 32953967 Free PMC article.
Transcatheter leadless pacemaker implantation in a patient with failing transvenous pacemaker and total occlusion of superior vena cava.
Dell'Era G, Porcellini S, Boggio E, Prenna E, Gravellone M, Varalda M, Erbetta R, Lio V, Occhetta E, Marino P. Dell'Era G, et al. Among authors: gravellone m. J Cardiovasc Med (Hagerstown). 2018 Sep;19(9):511-512. doi: 10.2459/JCM.0000000000000689. J Cardiovasc Med (Hagerstown). 2018. PMID: 29985798 No abstract available.
A clinical-in silico study on the effectiveness of multipoint bicathodic and cathodic-anodal pacing in cardiac resynchronization therapy.
Dell'Era G, Gravellone M, Scacchi S, Franzone PC, Pavarino LF, Boggio E, Prenna E, De Vecchi F, Occhetta E, Devecchi C, Patti G. Dell'Era G, et al. Among authors: gravellone m. Comput Biol Med. 2021 Sep;136:104661. doi: 10.1016/j.compbiomed.2021.104661. Epub 2021 Jul 22. Comput Biol Med. 2021. PMID: 34332350 Free article.
Effect of SAcubitril/Valsartan on left vEntricular ejection fraction and on the potential indication for Implantable Cardioverter Defibrillator in primary prevention: the SAVE-ICD study.
Guerra F, Ammendola E, Ziacchi M, Aspromonte V, Pellegrino PL, Del Giorno G, Dell'Era G, Pimpini L, Santoro F, Floris R, Stronati G, Nigro G, Paolisso P, Guido A, Maglia G, Brunetti ND, Carbone A, Gravellone M, Antonicelli R, Cannone M, Accogli M, Dello Russo A, Palmisano P. Guerra F, et al. Among authors: gravellone m. Eur J Clin Pharmacol. 2021 Dec;77(12):1835-1842. doi: 10.1007/s00228-021-03189-8. Epub 2021 Jul 19. Eur J Clin Pharmacol. 2021. PMID: 34279677
Incremental value of right atrial strain for early diagnosis of hemodynamic deterioration in pulmonary hypertension: a new noninvasive tool for a more comprehensive diagnostic paradigma.
Piccinino C, Giubertoni A, Zanaboni J, Gravellone M, Sola D, Rosso R, Ferrarotti L, Marino PN. Piccinino C, et al. Among authors: gravellone m. J Cardiovasc Med (Hagerstown). 2017 Nov;18(11):866-874. doi: 10.2459/JCM.0000000000000525. J Cardiovasc Med (Hagerstown). 2017. PMID: 28650932
COMPASS criteria applied to a contemporary cohort of unselected patients with stable coronary artery diseases: insights from the START registry.
De Luca L, Formigli D, Meessen J, Uguccioni M, Cosentino N, Paolillo C, Di Lenarda A, Colivicchi F, Gabrielli D, Gulizia MM, Scherillo M; START Investigators. De Luca L, et al. Eur Heart J Qual Care Clin Outcomes. 2021 Sep 16;7(5):513-520. doi: 10.1093/ehjqcco/qcaa054. Eur Heart J Qual Care Clin Outcomes. 2021. PMID: 32559279
Clinical outcomes, pharmacological treatment, and quality of life of patients with stable coronary artery diseases managed by cardiologists: 1-year results of the START study.
De Luca L, Temporelli PL, Riccio C, Gonzini L, Marinacci L, Tartaglione SN, Costa P, Scherillo M, Senni M, Colivicchi F, Gulizia MM; START Investigators. De Luca L, et al. Eur Heart J Qual Care Clin Outcomes. 2019 Oct 1;5(4):334-342. doi: 10.1093/ehjqcco/qcz002. Eur Heart J Qual Care Clin Outcomes. 2019. PMID: 30649303
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.
Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, Kastelein JJP, Cornel JH, Pais P, Pella D, Genest J, Cifkova R, Lorenzatti A, Forster T, Kobalava Z, Vida-Simiti L, Flather M, Shimokawa H, Ogawa H, Dellborg M, Rossi PRF, Troquay RPT, Libby P, Glynn RJ; CANTOS Trial Group. Ridker PM, et al. N Engl J Med. 2017 Sep 21;377(12):1119-1131. doi: 10.1056/NEJMoa1707914. Epub 2017 Aug 27. N Engl J Med. 2017. PMID: 28845751 Free article. Clinical Trial.